heart failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria are included in this study. 1.Patients who are admitted to Tokyo women's medical university cardiology department. 2.Patients who are at age of 20 at the time of consenting. 3.The heart failure is diagnosed according to Framingham criteria. 4.Patients with heart failure classified as AHA stage C to D. 5.Patients who are capable of giving their consent in a written form.
Exclusion criteria
Exclusion criteria: 1.Patients are admitted as Acute heart failure, Acute on chronic heart failure,and who need using mechanical support or infusion of a diuretic. 2.Acute coronary syndrome require emergent revascularization. 3.Patients who are pathologically difficult to ingest. 4.Patients with dialysis therapy. 5.Patients with Na levels =< 130 mEq/L 6.Patients with Hb levels =< 10.0mg/dl 7.Patients with malignancy(except those who are completely cured) 8.Patients with infection treatment. 9.Patients with other conditions that the attending physician think inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical stability(clinical congestion score: CCS) at 7-day assessment is the primary end point. | — |
Secondary
| Measure | Time frame |
|---|---|
| BNP, NT-proBNP, ANP, body weight, use of diuretics, sodium, Inbody, CTR, QOL | — |
Countries
Japan
Contacts
Tokyo Womens Medical University Cardiology